CLINICAL_TRIALS
withdrawal
· 2022-09-22
Clinical Trial Update: Adipose Stromal Cells Injection in the Myocardium for Induction of Revascularization [Phase 3]
Summary
Phase 3 trial of adipose stromal cell injection in the myocardium for revascularization was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hospital do Coracao | Conditions: Ischemic Heart Disease, Myocardial Ischemia | Phase 3 | Status: WITHDRAWN